In patients with advanced AKI, arrangements for renal replacement therapy need to be made before the onset of life-threatening uraemic complications.Conclusions. (AKI) is usually common in hospitalised patients, especially in those who are critically ill [1,2]. The Kidney Disease Improving Global Outcomes (KDIGO) working group estimates a worldwide AKI prevalence of ~2100 people per million populace [3]. There is increasing acknowledgement that even a minor acute reduction in renal function is usually independently associated with a poor end result, including higher risk of complications, longer stay in hospital, high mortality, and increased risk of needing long-term dialysis [49]. Although there is no curative therapy for AKI, research over the past decade has recognized various means to prevent or limit AKI. Regrettably, ACTB-1003 these are not widely known and are variably practised worldwide resulting in lost opportunities to improve the care and outcomes of patients with AKI. Importantly, there is no unifying approach to the care of these patients. There is a worldwide need to recognise patients at risk ACTB-1003 of AKI, to intervene early, and to circumvent the need for renal replacement therapy (RRT). Although a large proportion of patients presenting to the Emergency Department (ED) either have AKI or develop AKI later in hospital, the literature regarding epidemiology and management of such patients in the ED setting is usually lacking. In the UK, the recent National Confidential Enquiry into Patient Outcomes and Death (NCEPOD) report found that AKI is often underrecognised and poorly managed. The statement made a strong call for better education and training [10]. To our best knowledge, neither the College of Emergency Medicine (UK), American College of Emergency Physicians, Australasian College for Emergency Medicine, nor Canadian Association of Emergency Physicians have published guidelines on management of AKI in the ED. This review is designed to summarise existing knowledge about the management of AKI with particular emphasis on specific patient groups in the ED setting. == 2. Definition of AKI MCMT == The literature contains >50 definitions for AKI which has posed significant problems for comparative epidemiology and clinical research. In the last 10 years, efforts have been made to standardise the definition of AKI. In 2004, the Risk-Injury-Failure-Loss-Endstage (RIFLE) criteria were published, followed by the revised AKI Network (AKIN) classification in 2007 [11,12] (Table 1). Both definitions will soon be superceded by the KDIGO criteria which define AKI by any of the following: == Table 1. == Classifications to define AKI. (a) RIFLE classification [11] (b) AKI Network classification [12] (c) KDIGO classification [3] Abbreviations: GFR: glomerular filtration rate; RRT: renal replacement therapy; SCr: serum creatinine. Only one criterion needs to be met to be classified as AKI; if both are present, the criterion which places the patient in the higher stage of AKI is usually selected. increase in serum creatinine by 0.3 mg/dL (>26.5mol/L) within 48 hours; increase in serum creatinine to 1 1.5 times baseline, which is known or presumed to have occurred within prior 7 days; or urine volume <0.5 mL/kg/h for 6 hours. The level of the AKI burden in ED is not known. However, the key issue is that even relatively minor acute changes in serum creatinine impartial of underlying aetiology represent significant deterioration of renal function and are associated with poor end result [4]. == 3. Pathophysiology of AKI == There is increasing evidence that AKI is an inflammatory process involving complex interactions between vascular, tubular, and inflammatory factors. It is often precipitated by sepsis/systemic inflammatory response syndrome, renal hypoperfusion, volume depletion, and nephrotoxicity. In most cases, the aetiology is usually multifactorial. Patients with pre-existing comorbidities including diabetes, ACTB-1003 cirrhosis/hepatic failure, congestive heart failure, pre-existing chronic kidney disease (CKD), peripheral vascular disease and advanced age are at particular risk of AKI during an acute illness. == 4. Diagnosis of AKI == The symptoms of AKI may be vague, nonspecific, or even absent. The diagnosis of AKI currently depends on detection of reductions in kidney function by standard surrogate markers, such as serum creatinine and urine output. However, both are known to have significant limitations. Furthermore, the RIFLE, AKIN, and KDIGO criteria for AKI are based on relative changes in serum creatinine from baseline. If a baseline creatinine is not known it would seem prudent to presume that any elevated laboratory creatinine is usually AKI until confirmed otherwise. Furthermore, creatinine rises are typically seen 2436 hours after the initial insult which.